gptkbp:instance_of
|
gptkb:Company
|
gptkbp:bfsLayer
|
4
|
gptkbp:bfsParent
|
gptkb:Under_Siege
gptkb:Warhammer_40,000:_Dakka_Squadron
|
gptkbp:acquired
|
Big Pharma Inc.
|
gptkbp:awards
|
Best Startup 2021
Tech Innovator 2022
|
gptkbp:benefits
|
gptkb:healthcare_organization
|
gptkbp:business_model
|
B2 B
|
gptkbp:category
|
In-Vitro Diagnostics
|
gptkbp:ceo
|
gptkb:John_Doe
|
gptkbp:certification
|
gptkb:standard
|
gptkbp:client
|
Hospital Group A
|
gptkbp:collaborations
|
Research Institute Y
|
gptkbp:community_engagement
|
Health Awareness Campaigns
|
gptkbp:competitors
|
Bio Tech Corp.
|
gptkbp:customer_base
|
Hospitals and Clinics
|
gptkbp:employees
|
gptkb:television_series
|
gptkbp:expansion_plans
|
Asia Market
|
gptkbp:financial_performance
|
Annual Report 2022
|
gptkbp:financial_products
|
Angel Investors C
|
gptkbp:founded
|
gptkb:2000
|
gptkbp:founder
|
gptkb:Jane_Smith
|
gptkbp:grants
|
Government Funding
|
gptkbp:headcount
|
150
|
gptkbp:headquarters
|
City A
|
https://www.w3.org/2000/01/rdf-schema#label
|
Mikro Gen
|
gptkbp:industry
|
gptkb:Company
|
gptkbp:invention
|
Patent 123456
|
gptkbp:investment
|
gptkb:Venture_Capital_Firm_B
|
gptkbp:key
|
Customer Satisfaction
|
gptkbp:market
|
Global
15% in Diagnostics
New Test Kit 2023
|
gptkbp:operates_in
|
gptkb:Europe
|
gptkbp:partnerships
|
University X
Local NG Os
|
gptkbp:products
|
High Standards
Diagnostic Kits
|
gptkbp:research_and_development
|
20% of revenue
|
gptkbp:research_focus
|
Infectious Diseases
|
gptkbp:revenue
|
10 million USD
|
gptkbp:social_responsibility
|
Community Health Programs
|
gptkbp:strategic_importance
|
Market Leadership
|
gptkbp:student_enrollment
|
85%
|
gptkbp:subsidiary
|
Mikro Gen USA
|
gptkbp:supply_chain
|
Local Suppliers
|
gptkbp:sustainability_initiatives
|
Green Manufacturing
|
gptkbp:technology
|
PCR Technology
|
gptkbp:trademark
|
Mikro Gen Logo
|
gptkbp:training
|
Employee Development
|
gptkbp:website
|
www.mikrogen.com
|